The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)
A pill has to make it through your digestive system, and that process becomes less reliable with age, certain medications, and some diets
The choice between cyanocobalamin and hydroxocobalamin might also depend on the neurological symptoms
Community sources note that this creates a procurement barrier for research-context use, which is one reason the peptide-vendor channel and compounding pharmacy alternatives exist
In extreme circumstances, dementia
What is the point of living longer if you don't enjoy it